Metabolic Effects of Hydrochlorothiazide and Enalapril During Treatment of the Hypertensive Diabetic Patient: Enalapril for Hypertensive Diabetics

Keyphrases

• Enalapril 100%
• Diabetic Patients 100%
• Metabolic Effects 100%
• Hydrochlorothiazide 100%
• Hypertensive Diabetic 100%
• Glucose Homeostasis 37%
• Blood Pressure 25%
• Placebo 25%
• Monotherapy 25%
• Monocytes 12%
• Blood Pressure Control 12%
• Hypertensive 12%
• Clamping Method 12%
• Blood Glucose 12%
• Cholesterol 12%
• Metabolic Complications 12%
• Type 2 Diabetic Patients 12%
• High-density Lipoprotein Cholesterol (HDL-C) 12%
• Triglyceride Level 12%
• Hyperinsulinemic-euglycemic Clamp 12%
• Insulin Binding 12%
• Hemoglobin A1c (HbA1c) 12%
• Potassium Chloride 12%
• Lipid Homeostasis 12%
• Fasting Plasma Glucose 12%
• Fasting Insulin 12%
• Hypertension Management 12%
• A1c Levels 12%
• Total Cholesterol Level 12%
• Serum Insulin Levels 12%
• Hepatic Glucose Production 12%
• Peripheral Insulin Sensitivity 12%
• Enalaprilat 12%

Biochemistry, Genetics and Molecular Biology

• Hydrochlorothiazide 100%
• Blood Pressure 42%
• Low Drug Dose 42%
• Glucose Homeostasis 42%
• Glucose Blood Level 14%
• Insulin Sensitivity 14%
• Insulin Binding 14%
• Triacylglycerol Level 14%
• Lipid Homeostasis 14%
• Insulin Blood Level 14%
• High Density Lipoprotein Cholesterol Level 14%
• Glycosylated Hemoglobin 14%
• Total Cholesterol Level 14%
• Sitting 14%